Tilray | TRLY - Loan Capital

Stock Price
10.93
Daily Change
0.23 2.15%
Monthly
-4.29%
Yearly
893.64%
Q1 Forecast
10.37

Tilray reported $279.22M in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Acasti Pharma USD 0 0 Dec/2024
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Canopy Growth CAD 226.33M 62.67M Sep/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Moderna USD 610M 584M Dec/2025
Organigram Holdings CAD 76.4M 23.6M Sep/2025
Organon & Co USD 8.78B 117M Sep/2025
Revvity USD 2.63B 543K Dec/2025
Tectonic Therapeutic USD 100K 86K Sep/2025
Tilray USD 279.22M 18.87M Mar/2025
Viatris USD 12.48B 7M Dec/2025
Xeris Pharmaceuticals USD 219.47M 839K Sep/2025